Breast cancer risk assessment for screening: a hybrid artificial intelligence approach
European Radiology · 11.09.2025 · 36 (3) · 1932-1942
DOI: 10.1007/s00330-025-11980-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, online erschienen am 11.09.2025. Verfasst von Raquel Tendero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Tecnológico de la Informática, Universitat Politècnica de València, Camino de Vera s/n, 46022, València, Spain. Hauptthemen laut MEDLINE: Breast Neoplasms, Artificial Intelligence, Mammography, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Objectives
This study evaluates whether integrating clinical data with mammographic features using artificial intelligence (AI) improves 2-year breast cancer risk prediction compared to using either data type alone. Materials and methods This retrospective nested case-control study included 2193 women (mean age, 59 ± 5 years) screened at Hospital del Mar, Spain (2013–2020), with 418 cases (mammograms taken 2 years before diagnosis) and 1775 controls (cancer-free for ≥ 2 years). Three models were evaluated: (1) ERTpd + im, based on Extremely Randomized Trees (ERT), split into sub-models for personal data (ERTpd) and image features (ERTim); (2) an image-only model (CNN); and (3) a hybrid model (ERTpd + im + CNN). Five-fold cross-validation, area under the receiver operating characteristic curve (AUC), bootstrapping for confidence intervals, and DeLong tests for paired data assessed performance. Robustness was evaluated across breast density quartiles and detection type (screen-detected vs. interval cancers).
Results
The hybrid model achieved an AUC of 0.75 (95% CI: 0.71–0.76), significantly outperforming the CNN model (AUC, 0.74; 95% CI: 0.70–0.75; p < 0.05) and slightly surpassing ERT pd + im (AUC, 0.74; 95% CI: 0.70–0.76). Sub-models ERT pd and ERT im had AUCs of 0.59 and 0.73, respectively. The hybrid model performed consistently across breast density quartiles ( p > 0.05) and better for screen-detected (AUC, 0.79) than interval cancers (AUC, 0.59; p < 0.001).
Conclusions
This study shows that integrating clinical and mammographic data with AI improves 2-year breast cancer risk prediction, outperforming single-source models. The hybrid model demonstrated higher accuracy and robustness across breast density quartiles, with better performance for screen-detected cancers. Key Points Question Current breast cancer risk models have limitations in accuracy. Can integrating clinical and mammographic data using artificial intelligence (AI) improve short-term risk prediction?
Findings
A hybrid model combining clinical and imaging data achieved the highest accuracy in predicting 2-year breast cancer risk, outperforming models using either data type alone . Clinical relevance Integrating clinical and mammographic data with AI improves breast cancer risk prediction. This approach enables personalized screening strategies and supports early detection. It helps identify high-risk women and optimizes the use of additional assessments within screening programs .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto Tecnológico de la Informática, Universitat Politècnica de València, Camino de Vera s/n, 46022, València, Spain.
- Universitat Politècnica de València, Camino de Vera s/n, 46022, València, Spain.
- Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Research Institute), Passeig Marítim 25-29, 08003, Barcelona, Spain.
- Instituto Tecnológico de la Informática, Universitat Politècnica de València, Camino de Vera s/n, 46022, València, Spain. rllobet@dsic.upv.es.
- Universitat Politècnica de València, Camino de Vera s/n, 46022, València, Spain. rllobet@dsic.upv.es.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Tendero, R., Larroza, A., Pérez-Benito, F. J., Perez-Cortes, J. C., Román, M., & Llobet, R. (2025). Breast cancer risk assessment for screening: a hybrid artificial intelligence approach. European Radiology, 36(3), 1932-1942. https://doi.org/10.1007/s00330-025-11980-9
Vancouver
Tendero R, Larroza A, Pérez-Benito FJ, Perez-Cortes JC, Román M, Llobet R. Breast cancer risk assessment for screening: a hybrid artificial intelligence approach. European Radiology. 2025;36(3):1932-1942. doi:10.1007/s00330-025-11980-9
BibTeX
@article{Tendero2025,
author = {Tendero, Raquel and Larroza, Andrés and Pérez-Benito, Francisco Javier and Perez-Cortes, Juan Carlos and Román, Marta and Llobet, Rafael},
title = {Breast cancer risk assessment for screening: a hybrid artificial intelligence approach},
journal = {European Radiology},
year = {2025},
volume = {36},
number = {3},
pages = {1932--1942},
doi = {10.1007/s00330-025-11980-9}
}
EUVIMED